The purpose of this study was to clarify the effect of aging on brain γ-aminobutyric acid metabolism. We measured the cerebrospinal fluid γ-aminobutyric acid concentration in subjects of various ages, including healthy volunteers and patients without neurological or psychiatric disease. The cerebrospinal fluid γ-aminobutyric acid concentration was determined by radiolabelled receptor assay using [ 3 Hty-aminobutyric acid. Cerebrospinal fluid γ-aminobutyric acid was significantly higher in the control group (20s and 30s) than in the groups of subjects in their 50s, 60s, 70s and 80s. There was a significant negative correlation between cerebrospinal γ-aminobutyric acid concentration and age (p < 0.01). These data suggest that dysfunction of brain γ-aminobutyric acid metabolism increases with age, and that the various symptoms caused by abnormal γ-aminobutyric acid metabolism in the brain are therefore more likely to appear in elderly people.
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Subjects and Methods

Subjects
The subjects consisted of 55 healthy volunteers and patients without neurological or psychiatric disease (30 men and 25 women) who were not receiving drugs that act on the central nervous system. Their ages ranged from 21 to 82 years (mean ± SD, 48.4 ± 18.9). The age distribution is shown in table 1. Those in their 20s and 30s were used as controls, and were compared with the other subjects.
Procedures
All subjects were maintained on absolute bed rest, and oral intake was forbidden for the 15 hours before the cerebrospinal fluid sample was taken. Some of the patients were not taking medication. In the others, drug therapy was stopped for at least 14 days before the sample was taken. Lumbar puncture was performed at 9 am, in the standard fashion with the patients in the lateral decubitus position. Ten millilitres of cerebrospinal fluid were withdrawn and the final 5 ml was immediately frozen by immersion in a mixture of acetone and solid carbon dioxide, and kept at -70 °C until assayed.
Receptor preparation
For the receptor preparation, crude synaptic membrane was prepared from whole rat brains by a modification of the method of De Robertis et al. (9) . Briefly, Sprague-Dawley rats (body weight 200 -250 g) were decapitated and the whole brains were immediately removed. The tissue was homogenized in 10 volumes of an ice-cold 0.32 mol/1 sucrose solution in a Brinkman Polytron PT-10 homogenizer for 20 s. The homogenate was centrifuged at 900 g for 10 min, and the supernatant was further centrifuged at 11 500 g for 20 min. The pellet (P 2 fraction) was resuspended in 10 volumes of Tris-HCl buffer (50 mmol/1, pH 7.6) and kept at -70 °C until assayed. Before analysis, the receptor preparation was thawed and homogenized with a glass homogenizer in 100 volumes of Tris-HCl buffer, then centrifuged at 50 000 g for 20 min. The supernatant was discarded and the pellet was resuspended in 100 volumes of Tris-HCl buffer containing 0.5 ml/1 Triton X-100. The suspension was shaken in a water bath at 37 °C for 30 min, then centrifuged twice at 50 000 g for 20 min. The pellet was resuspended in 20 volumes of Tris-HCl buffer. This gave a tissue protein concentration of about 0.6 g/1.
Determination of γ-aminobutyric acid in cerebrospinal fluid
The cerebrospinal fluid γ-aminobutyric acid concentration was measured by the radiolabelled receptor assay method of Enna & Snyder (10) as modified by Kuroda et al. (4), with crude synaptic membranes prepared from the rat brain. In brief, 0.5 ml of the receptor preparation was placed in a glass tube containing 0.2 ml of various concentrations (100 pmol/1 -10 μιηοΐ/ΐ, final concentration) of γ-aminobutyric acid (for standard curve) or cerebrospinal fluid, 0.2 ml of Tris-HCl buffer and 0.1 ml of [ 3 Hty-aminobutyric acid (final concentration 6.4 nmol/1, specific activity 2109 TBq/mol (57 Ci/mmol), Amersham). The samples were incubated in ice for 30 min and the reaction was stopped by filtration through glass fibre filters (Whatman GF/C) under reduced pressure. Finally, each filter was washed twice with 5 ml of cold Tris-HCl buffer, then placed in a scintillation vial with 10ml of scintillation fluor. The radioactivity of the filter was counted with an automatic beta counter. Specific binding was obtained by subtracting from the total bound radioactivity the amount not displaced by 1 mmol/1 γ-aminobutyric acid (blank). All samples were analysed in triplicate. Cerebrospinal fluid γ-aminobutyric acid concentrations were calculated with the aid of the standard γ-aminobutyric acid radiolabelled receptor assay curve.
Post hoc Dunnett's multiple comparison test (11) was performed following one-way analysis of variance to compare the cerebrospinal fluid γ-aminobutyric acid concentrations in controls with those in the other age groups.
All data are expressed as means + SEMs. Table 1 shows the cerebrospinal fluid γ-aminobutyric acid concentrations in each age group. The concentrations were significantly lower in subjects who were at least 50 years old than in those who were less than 40 years old. Figure 1 shows that there was a significant negative correlation between cerebrospinal fluid γ-aminobutyric acid concentration and age (p < 0.01). This was true for the group as a whole, and also when the data from the men and the women were analysed separately (p < 0.01). The age-related decrease was slightly greater, and the correlation was slightly stronger in women.
Results
• (12, 13) . In 1954, Hayashi (14) reported inhibition of seizures after γ-aminobutyric acid was injected into the cerebral cortex of mammals. This suggested that γ-aminobutyric acid is an inhibitory neurotransmitter, and subsequent studies have confirmed this. Radiolabelled receptor assays (15) can be used to observe changes in neuro-transmission, and this type of assay has also contributed to studies of γ-aminobutyric acid receptors. Kuroda (16) has already reported that the dilution curve of cerebrospinal fluid is parallel to the standard γ-aminobutyric acid radiolabelled receptor assay curve, and that the crossreactivity of glycine, L-glutamic acid, and taurine is less than 0.02%. The cerebrospinal fluid γ-aminobutyric acid concentration could be measured accurately down to 5 nmol/1 by the radiolabelled receptor assay. The existence of rostrocaudal γ-aminobutyric acid concentration gradients (16) suggests that the cerebrospinal fluid γ-aminobutyric acid may reflect brain γ-aminobutyric acid system activity. Although the γ-aminobutyric acid concentration is about 50% lower in the cerebrospinal fluid than in plasma, γ-acetylenic γ-aminobutyric acid, which is known to increase brain γ-aminobutyric acid, increased both plasma and cerebrospinal γ-aminobutyric acid in a dose dependent manner (17) . These data indicate that the cerebrospinal fluid γ-aminobutyric acid originates from the brain and is minimally affected by changes in the peripheral γ-aminobutyric acid concentration.
We previously reported the cerebrospinal fluid γ-aminobutyric acid concentrations in patients with various neurological and psychiatric diseases, as measured by radiolabelled receptor assay (4, 5) . In this study, to evaluate changes in brain γ-aminobutyric acid metabolism with age, the cerebrospinal fluid γ-aminobutyric acid concentrations were compared among subjects of various ages, consisting of both normal volunteers and patients without neurological or psychiatric disease. The cerebrospinal fluid γ-aminobutyric acid concentrations were significantly lower in the subjects who were at least 50 years old than in those who were less than 40 years old (tab. 1). In addition, the cerebrospinal fluid γ-aminobutyric acid concentration was negatively correlated with age, in both men and women ( fig. 1) . In particular, the cerebrospinal fluid γ-aminobutyric acid concentrations of subjects in their 70s and 80s were about 50% and 30%, respectively, of the concentration in the control group.
Hare et al. (18) reported an age-related significant decrease in cerebrospinal fluid γ-aminobutyric acid concentration among women, but only a slight decrease among men. In this study, computed tomography scans showed relatively slight atrophic changes in the brain (data not shown). Therefore, the decrease in cerebrospinal fluid γ-aminobutyric acid concentration was probably associated with abnormal γ-aminobutyric acid metabolism, rather than with a decrease in γ-aminobutyric acid content due to agerelated atrophy of the cerebral cortex and cerebellum, which contain large amounts of γ-aminobutyric acid. McGeer (19) reported an age-related decrease in the activity of glutamic acid decarboxylase, which is a γ-aminobutyric acid synthetase. This might decrease the brain γ-aminobutyric acid concentration and thus decrease the cerebrospinal fluid γ-aminobutyric acid concentration. Involuntary movements are frequently seen in the elderly, and memory is gradually impaired. A decrease in the cerebrospinal fluid γ-aminobutyric acid concentration has been reported in Alzheimer's disease, which is characterized by dementia, in Huntington's disease, which is characterized by involuntary movements, and in Parkinson's disease (6 -8, 20) . In particular, diseases characterized by involuntary movements have been said to be closely associated with γ-aminobutyric acid metabolism (6, 21) .
Although the brain γ-aminobutyric acid system is not the only system involved in the aging process, the present study showed that the cerebrospinal fluid γ-aminobutyric acid concentration markedly decreased with age. This suggests that brain γ-aminobutyric acid metabolism is closely associated with various symptoms in the aged, and that the measurement of cerebrospinal fluid γ-aminobutyric acid can be used to evaluate this association.
